Session Information
ENDO 2011 Annual Meeting
Click here to go to the previous page
Advances in the Management of Acromegaly
Track
:
CLINICAL
Program Code:
S29
SPEAKER
(S):
Philippe Chanson, MD,MS, Hosp Bicetre
Disclosures: PC: Advisory Group Member, Eli Lilly & Company; Clinical Researcher, Ipsen, Merck & Co., Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Inc.
Disclosures: PC: Advisory Group Member, Eli Lilly & Company; Clinical Researcher, Ipsen, Merck & Co., Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Inc.
Stephan Petersenn, MD, ENDOC Ctr for Endocrine TumorsDisclosures: SP: Advisory Group Member, Speaker, Novartis Pharmaceuticals, Ipsen.
No items are available for this session.